Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Japan flag Japan · Delayed Price · Currency is JPY
1,366.00
-4.00 (-0.29%)
Feb 13, 2026, 3:30 PM JST
Market Cap40.06B +28.8%
Revenue (ttm)51.20B +8.1%
Net Income2.23B -15.8%
EPS74.32 -13.5%
Shares Out29.24M
PE Ratio18.43
Forward PE17.18
Dividend40.00 (2.96%)
Ex-Dividend DateMay 28, 2026
Volume44,500
Average Volume84,940
Open1,367.00
Previous Close1,370.00
Day's Range1,350.00 - 1,370.00
52-Week Range970.00 - 1,395.00
Beta0.25
RSI55.69
Earnings DateApr 17, 2026

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its nam... [Read more]

Sector Healthcare
Founded 1942
Employees 1,073
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4577
Full Company Profile

Financial Performance

In fiscal year 2025, Daito Pharmaceutical's revenue was 50.64 billion, an increase of 7.99% compared to the previous year's 46.90 billion. Earnings were 1.91 billion, a decrease of -42.09%.

Financial Statements